Ratings by WBB Securities (Steve Brozak)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/18/2021 | Omeros Corp. | OMER | Maintain | Strong Buy (N/A) |
|
Details | ||
| 5/28/2021 | Redhill Biopharma | RDHL | Downgrade | Buy (Strong Buy) |
7.14 (7.00) |
-1.96% | Details | |
| 4/23/2021 | Paratek Pharmaceuticals | PRTK | Upgrade | Buy (Speculative Buy) |
7.87 (7.23) |
-8.13% | Details | |
| 3/31/2021 | ContraFect Corp. | CFRX | New Coverage | Speculative Buy (N/A) |
4.48 (4.23) |
-5.58% | Details | |
| 1/8/2020 | Paratek Pharmaceuticals | PRTK | New Coverage | Speculative Buy (N/A) |
4.15 (7.23) |
74.22% | Details | |
| 7/12/2019 | Redhill Biopharma | RDHL | Upgrade | Strong Buy (Buy) |
6.59 (7.00) |
6.22% | Details | |
| 3/29/2019 | Marker Therapeutics | MRKR | Upgrade | Strong Buy (Buy) |
6.71 (3.20) |
-52.31% | Details | |
| 3/12/2019 | Redhill Biopharma | RDHL | Upgrade | Buy (Speculative Buy) |
8.27 (6.59) |
-20.31% | Details |
